30-04-2021

Insulin Copay



BASAGLAR comes with options* that may help make insulin therapy more affordable.

  1. Insulin Copay Cap Virginia
  2. Insulin Copay Card
  3. Insulin Copay Reduction
  4. Insulin Copay Cap Legislation
  5. Insulin Copays

Insulin Copay Cap Virginia

Copay

What is Lantus ® (insulin glargine injection) 100 Units/mL? Prescription Lantus is a long-acting insulin used to treat adults with type 2 diabetes and adults and pediatric patients (children 6 years and older) with type 1 diabetes for the control of high blood sugar. Do not use Lantus to treat diabetic ketoacidosis. Important Safety Information. Offer valid for one fill per month. To pay $99 per month, you must fill all your Sanofi Insulin prescriptions at the same time, together each month. Not valid for SOLIQUA 100/33 (insulin glargine and lixisenatide injection) 100 Units/mL and 33 mcg/mL. When using the Insulins Valyou Savings Card, prices are guaranteed for 12 consecutive monthly fills.

With a monthly savings card,† BASAGLAR may help your eligible commercially insured patients get off to a good start and help keep the cost to as little as $5 per month.†

*For eligible patients.

Insulin Copay

Insulin Copay Card

†By using the Basaglar Savings Card (“Card”), you attest that you meet the eligibility criteria, agree to and will comply with the terms and conditions described below:
Offer good until 12/31/2021 for up to 24 prescriptions. Patient must have commercial drug insurance with insurance provider coverage for BASAGLAR to pay as little as $5 for 5 BASAGLAR KwikPens (1 carton). Offer subject to a monthly cap of $150 and a separate $1800 maximum annual cap. Offer void where prohibited by law. Patient is responsible for any applicable taxes, fees, or amounts exceeding monthly or annual caps. This offer is invalid for patients without commercial drug insurance or whose prescription claims for BASAGLAR are eligible to be reimbursed, in whole or in part, by any governmental program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medigap, DoD, VA, TRICARE®/CHAMPUS, or any state patient or pharmaceutical assistance program. This offer is not valid for: Massachusetts residents if an ABrated generic equivalent is available; California residents if an FDAapproved therapeutic equivalent is available.
Available only in the US and Puerto Rico for residents of the US and Puerto Rico. By accepting this offer, you agree that if you are required to do so under the terms of your insurance coverage for this prescription or are otherwise required to do so by law, you should notify your insurance carrier of your redemption of this Card. This offer cannot be combined or utilized with any other program, discount, discount card, cash discount card, coupon, incentive, or similar offer involving BASAGLAR. It is prohibited for any person to sell, purchase or trade; or to offer to sell, purchase or trade, or to counterfeit this Card. This offer may be terminated, rescinded, revoked, or amended by Lilly USA, LLC at any time without notice. Card activation required. This Card is not health insurance. This Card expires on 12/31/2021.

Each card has a unique ID number. Please do not make copies.

Lilly may be able to help those patients who are not eligible for a BASAGLAR Savings Card or need additional assistance. Call the Lilly Diabetes Solution Center at 1-833-808-1234.

Insulin Copay Reduction

Lilly is committed to helping people with diabetes regardless of whether they have insurance from an employer, Medicare, or no insurance at all. Visit insulinaffordability.com for information on:

Insulin Copay

Insulin Copay Cap Legislation

  • The Lilly Diabetes Solution Center, offering confidential conversations with patients to determine their eligibility for solutions based on their circumstances
  • Discount programs
  • Savings cards
  • Medicare coverage
SELECT SAFETY INFORMATION
DRUG INTERACTIONS

Insulin Copays

Certain drugs may affect glucose metabolism, requiring insulin dose adjustment and close monitoring of blood glucose. The signs and symptoms of hypoglycemia may be blunted when beta-blockers, clonidine, guanethidine, and reserpine are co-administered with BASAGLAR.